Reference intervals and method optimization for variables reflecting hypocoagulatory and hypercoagulatory states in dogs using the STA Compact® automated analyzer

Journal of Veterinary Diagnostic Investigation

Volumn 21, Issue 6, 2009, Pages 803-814

  Bauer, Natali ^a   Eralp, Oya ^a   Moritz, Andreas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Dogs; Fibrinolysis; Hemostasis; Interferences; Sex; Thrombophilia

Indexed keywords

CANIS FAMILIARIS;

EID: 70449397592     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870902100606     Document Type: Article

References (50)

1. Bauer N, Moritz A: 2008, Evaluation of three methods for measurement of hemoglobin and calculated hemoglobin parameters with the ADVIA 2120 and ADVIA 120 in dogs, cats, and horses. Vet Clin Pathol 37:173-179.
2. Bauer N, Moritz A: 2008, Koagulopathien bei Hund und Katze [Coagulopathy in dogs and cats]. Tierarztliche Praxis 36:235-246. In German. Abstract in English.
3. Bauer N, Moritz A: 2009, Evaluation of the Cardiac readerH as a point-of-care instrument for measurement of fibrin D-dimers in dogs. Tierärztliche Praxis. In press.
4. Brooks MB: 2004, Evaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasma. Vet Clin Pathol 33:208-214.
5. Bruhn HD, Schambeck CM, Hach-Wunderle V: 2007, Haufige Fehlerursachen [Common sources of error]. In: Hamostaseologie fur die Praxis [Haemostaseology for the practice], ed. Bruhn HD, Schambeck CM, Hach-Wunderle V, 1st ed., p. 29. Schattauer, Stuttgart, Germany. In German.
6. Bruhn HD, Schambeck CM, Hach-Wunderle V: 2007, Verarbeitung von Citratplasma [Preparation of citrated plasma]. In: Hämostaseologie fur die Praxis [Haemosteology for the practice], ed. Bruhn HD, Schambeck CM, Hach-Wunderle V, 1st ed., pp. 28-29. Schattauer, Stuttgart, Germany. In German.
7. Ceriotti F, Hinzmann R, Panteghini M: 2009, Reference intervals: the way forward. Ann Clin Biochem 46:8-17.
8. Clark P, Walker ID: 2001, The phenomenon known as acquired activated protein C resistance. Br J Haematol 115:767-773.
9. Dahlback B: 2008, Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112:19-27.
10. Dahlback B, Carlsson M, Svensson PJ: 1993, Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90:1004-1008.
11. de Laforcade AM, Freeman LM, Shaw SP, et al.: 2003, Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 17:674-679.
12. de Laforcade AM, Rozanski EA, Freeman LM, Li W: 2008, Serial evaluation of protein C and antithrombin in dogs with sepsis. J Vet Intern Med 22:26-30.
13. Diquelou A, Menaut P, Trumel C, Guelfi J: 2003, Validation of a D-Dimers assay, STA Liatest D-Di, by immunoturbidimetric methods [Abstract]. Vet Clin Pathol 32:219-232.
14. Dolan G, Neal K, Cooper P, et al.: 1994, Protein C, Geschlecht und Rasse [Activity of coagulation factors II, V, antithrombin III and plasminogen: effect of age, sex and VII and X in healthy dogs-dependence on age, sex and blood group. Br J Haematol 86:798-803.
15. Fang MC, Singer DE, Chang Y, et al.: 2005, Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 112:1687-1691.
16. Gunzel-Apel AR, Hayer M, Mischke R, et al.: 1997, Dynamics of haemostasis during the oestrous cycle and pregnancy in bitches. J Reprod Fertil Suppl 51:185-193.
17. Harris JM, Abramson N: 1997, Evaluation of recurrent thrombosis and hypercoagulability. Am Fam Physician 56:1591-1592.
18. Hedlin AM, Monkhouse FC, Milojevic SM: 1972, A comparative study of fibrinolytic activity in human, rat, rabbit, and dog blood. Can J Physiol Pharmacol 50:11-16.
19. Horn PS, Pesce AJ: 2003, Reference intervals: an update. Clin Chim Acta 334:5-23.
20. Hughes R, Thomson K, Hopkins R, et al.: 2005, Determinants of plasma D-dimer levels in a traveling population. J Thromb Haemost 3:2445-2448.
21. James AH: 2009, Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol 29:326-331.
22. Johnstone IB, Martin CA: 2000, Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog. Can J Vet Res 64:117-122.
23. Kappert G: 2002, Vergleichbarkeit der Methoden zur Bestimmung der aktivierten partiellen Thromboplastinzeit und der Resistenz gegen aktiviertes Protein C [Comparability of methods for measurement of activated partial thromboplastin time and resistance against activated protein C]. Heinrich-Heine University, Dusseldorf, Germany. In German. Abstract in English.
24. Karges HE, Funk KA, Ronneberger H: 1994, Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 44:793-797.
25. Keenan CR, White RH: 2007, The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 13:377-383.
26. Lanevschi A, Kramer JW, Greene SA, Meyers KM: 1996, Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs. Am J Vet Res 57:1124-1130.
27. Lippi G, Guidi GC: 2004, Effect of specimen collection on routine coagulation assays and D-dimer measurement. Clin Chem 50:2150-2152.
28. Lippi G, Montagnana M, Salvagno GL, Guidi GC: 2006, Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med 130:181-184.
29. Lutze G, Hartung KJ, Kutschmann K: 1992, Aktivitatsbestimmungen von Einzelfaktoren der Gerinnung bei klinisch gesunden Schweinen und Rindern [Determination of the activity of single coagulation factors in clinically healthy swine and cattle]. Berl Munch Tierarztl Wochenschr 105:411-414. In German. Abstract in English.
30. Lutze G, Kutschmann K: 1991, Untersuchungen zum plasmatischen Gerinnungssystem der Hauskatze [The plasma coagulation system of domestic cats]. Berl Munch Tierarztl Wochenschr 104:53-57. In German. Abstract in English.
31. Mansell PD, Parry BW, Van Orsouw PJ: 1990, Haemophilia A in a family of miniature poodles. Aust Vet J 67:420-421.
32. Mischke R: 1994, Aktivitat der Gerinnungsfaktoren II, V, VII und X beim gesunden Hund-Abhangigkeit von Alter, breed]. Berl Munch Tierarztl Wochenschr 107:289-294. In German. Abstract in English.
33. Mischke R: 2001, Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma. Am J Vet Res 62: 625-629.
34. Mischke R: 2005, Hamostase [Hemostasis]. In: Klinische Labordiagnostik in der Tiermedizin [Clinical laboratory diagnostics in veterinary medicine], ed. Kraft W, Durr UM, 6th ed., pp. 115-144. Schattauer, Stuttgart, Germany. In German.
35. Moreno P, Ginel PJ: 1999, Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs. Res Vet Sci 67:273-276.
36. Murtaugh RJ, Dodds WJ: 1988, Hemophilia A in a female dog. J Am Vet Med Assoc 193:351-352.
37. Oger E, Leroyer C, Bressollette L, et al.: 1998, Evaluation of a new, rapid, and quantitative D-dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med 158:65-70.
38. Ornstein DL, Cushman M: 2003, Cardiology patient page. Factor V Leiden. Circulation 107:e94-e97.
39. Reed GF, Lynn F, Meade BD: 2002, Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 9:1235-1239.
40. Sakata T, Okamoto A, Morita T, et al.: 2007, Ageand gender-related differences of plasma prothrombin activity levels. Thromb Haemost 97:1052-1053.
41. Solberg HE: 1987, Approved recommendation on the theory of reference values: part 5. Statistical treatment of reference values. Determination of reference limits. J Clin Chem Clin Biochem 25:645-656.
42. Stief TW: 2008, Influence of the surface on thrombin generation. Int J Lab Hematol 30:269-277.
43. Stocker K, Fischer H, Meier J, et al.: 1986, Protein C activators in snake venoms. Behring Inst Mitt 37-47.
44. Stocker K, Fischer H, Meier J, et al.: 1987, Characterization of the protein C activator Protac from the venom of the southern copperhead (Agkistrodon contortrix) snake. Toxicon 25:239-252.
45. Svensson PJ, Zoller B, Dahlback B: 1997, Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls. Thromb Haemost 77:332-335.
46. Toulza O, Center SA, Brooks MB, et al.: 2006, Evaluation of plasma protein C activity for detection of hepatobiliary disease and portosystemic shunting in dogs. J Am Vet Med Assoc 229:1761-1771.
47. van der ML, Reyers F: 2007, The effect of hemolysis on plasma antithrombin activity as determined by a chromogenic method. Vet Clin Pathol 36:55-59.
48. Vilar P, Couto CG, Westendorf N, et al.: 2008, Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med 22:374-379.
49. Walker FJ, Fay PJ: 1992, Regulation of blood coagulation by the protein C system. FASEB J 6:2561-2567.
50. Wiwanitkit V: 2002, Rejection of specimens for prothrombin time and relating pre-analytical factors in blood collection. Blood Coagul Fibrinolysis 13:371-372.